Skip to content

Sleep Actigraphy in Postural Tachycardia Syndrome (POTS)

Assessment of Objective Sleep Disturbances in Orthostatic Intolerance Using Actigraphy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00692471
Enrollment
100
Registered
2008-06-06
Start date
2008-06-30
Completion date
2029-12-31
Last updated
2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthostatic Intolerance, Postural Tachycardia Syndrome, Sleep Disorders

Keywords

Sleep, Orthostatic tachycardia, POTS

Brief summary

We propose to use actigraphy (measured by activity watches) as a tool to quantify sleep disturbances in patients with orthostatic intolerance compared with healthy control subjects. In this pilot study, we will test the null hypothesis (Ho) that there are no differences in the sleep quality between patients with orthostatic intolerance and healthy control subjects.

Detailed description

We propose to use actigraphy (measured by activity watches) as a tool to quantify sleep disturbances in patients with orthostatic intolerance compared with healthy control subjects. In this pilot study, we will test the null hypothesis (Ho) that there are no differences in the sleep quality between patients with orthostatic intolerance and healthy control subjects.

Interventions

DEVICEActigraphy Watch (motion sensors) with light sensors - ActiWatch from Minimitter

Watch to be worn on wrist for 7 days (except in water) that will measure activity/movement.

Sponsors

National Center for Research Resources (NCRR)
CollaboratorNIH
Satish R. Raj
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with orthostatic intolerance by the Vanderbilt Autonomic Dysfunction Center * Control subjects will be free of orthostatic intolerance and other major medical problems, free of medications during the study * Age between 18-65 years * Male and female subjects are eligible. * Able and willing to provide informed consent

Exclusion criteria

* Overt cause for postural tachycardia (such as acute dehydration) * Self-report of pregnancy * Inability to give, or withdrawal of, informed consent * Other factors which in the investigator's opinion would prevent the subject from completing the protocol

Design outcomes

Primary

MeasureTime frame
Sleep Latency1 week

Secondary

MeasureTime frame
Sleep Efficiency1 week
Wake After Sleep Onset1 week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026